戻る Agenda
Session 8: Assessing Individual Cases and Expedited Case Reporting, Part 2
Session Chair(s)
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
This session will provide a comparative overview of US and EU requirements, including sponsor review of investigator safety data. Several gnarly examples will be presented for group discussion.